Scientists test if standard drug doses work for obese patients

NCT ID NCT05589688

Recruiting now Knowledge-focused Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how body composition, specifically lean muscle mass, affects how the antiviral drug acyclovir is processed and eliminated by the kidneys. Researchers will enroll 20 healthy volunteers across four different body mass index (BMI) groups to measure drug levels in their blood and urine. The goal is to gather data to help doctors prescribe more accurate and effective doses for patients who are overweight or obese.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Toulouse Hospital
RECRUITING

Toulouse, France

Contact

Conditions

Explore the condition pages connected to this study.

OBESITY